Prof. Amos Toren
MD, PhD, MHA | Pediatric Hemato-Oncology & Bone Marrow Transplant Specialist
Department:
Pediatric Hemato-Oncology & BMT Division, Sheba Medical Center
Languages:
Hebrew, English
Professional Summary
Inside Sheba’s Hematology Ecosystem: Expertise Recognized by Forbes Israel
Prof. Amos Toren is a highly experienced pediatric hemato-oncologist and former Director of the Pediatric Hemato-Oncology and Bone Marrow Transplant Division at Sheba Medical Center. He is board-certified in pediatrics, general hematology, and pediatric hemato-oncology, with additional academic qualifications in genetics and healthcare management.
Prof. Toren is internationally recognized for his work in advanced therapies for pediatric cancers, particularly in the fields of immunotherapy and bone marrow transplantation. His clinical approach combines cutting-edge research with individualized treatment strategies for complex and high-risk cases.
Areas of Expertise
Pediatric oncology and hematologic malignancies
Leukemia and lymphoma in children and young adults
Bone marrow and stem cell transplantation
Immune deficiencies and chronic blood disorders
Treatment of rare and complex pediatric cancers
Advanced cellular therapies (including CAR T-cell approaches)
Education & Academic Background
MD, Faculty of Medicine, Tel Aviv University, Israel
Residency in Pediatrics, Sheba Medical Center
Residency in Hematology, Sheba Medical Center
Specialization in Pediatric Hemato-Oncology and Bone Marrow Transplantation, Hadassah Medical Center
PhD in Human Genetics, Tel Aviv University
Master of Health Administration (MHA), Recanati Business School, Tel Aviv University
Clinical & Research Experience
Prof. Toren has led one of Israel’s most advanced pediatric oncology and transplantation programs, treating both children and young adults (up to age 30) with complex malignancies.
His research focuses on:
CAR T-cell therapy for relapsed and resistant leukemias and lymphomas
cellular immunotherapy approaches (including cytokine-induced killer cells)
pediatric brain tumors
innovative targeted treatments in pediatric oncology
He is actively involved in translational research aimed at improving outcomes in treatment-resistant cancers.
International Collaboration
The department led by Prof. Toren maintains strong collaborations with leading global institutions, including:
St. Anna Children’s Hospital (Austria)
National Cancer Institute (NIH), USA
St. Jude Children’s Research Hospital, USA
Academic & Professional Roles
Former Director, Pediatric Hemato-Oncology & BMT Division
Former Head of Hematology Division, Tel Aviv University (two terms)
Member of leading international societies:
American Society of Hematology (ASH)
Children’s Oncology Group (COG)
European Society of Pediatric Hematology (ESPHI)
European Group for Blood and Marrow Transplantation (EBMT)
Center for International Blood and Marrow Transplant Research (CIBMTR)
Member, Israeli Ministry of Health Cord Blood Committee
Board Certifications
Pediatrics
Pediatric Hemato-Oncology
Bone Marrow Transplantation
Selected Publications
Immunoglobulin prophylaxis in pediatric stem cell transplantation
Overcoming resistance to PARP inhibitors in cancer therapy
Additional peer-reviewed publications in pediatric oncology and hematology
Why Patients Choose Prof. Toren
Extensive experience in complex pediatric oncology and transplantation
Expertise in advanced immunotherapies (including CAR T-cell approaches)
Strong integration of research and clinical practice
Leadership in a Top-10 globally ranked hospital
Experience with rare and treatment-resistant cases